logo
Select company
Select metric
$ 293.03MOperating Expenses
VS
Market
42
Sector
26
Industry
16
History
24
$ 12.64Close
$ 5.31 - $ 12.64 52-Week Range
Ticker Information

Ticker

RGNX

Company Name

REGENXBIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

REGENXBIO INC - Operating Expenses Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RGNX - Op. Exp. Historical data
DateOperating Expenses
6/30/2025$ 293.03M
3/31/2025$ 281.35M
12/31/2024$ 283.11M
9/30/2024$ 291.72M
6/30/2024$ 299.32M
3/31/2024$ 315.18M
12/31/2023$ 321.16M
9/30/2023$ 322.61M
6/30/2023$ 325.59M
3/31/2023$ 324.21M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • REGENXBIO INC's latest trailing twelve months (TTM) Op. Exp. stands at $ 221.55M.
  • Over the past 5 years, REGENXBIO INC's average Op. Exp. has been $ 286.93M.
  • The median Op. Exp. for REGENXBIO INC during this period was $ 292.38M
  • REGENXBIO INC reached its highest Op. Exp. over the past 5 years at $ 325.59M.
  • The lowest Op. Exp. recorded by REGENXBIO INC in the same timeframe $ 221.55M

REGENXBIO INC's Op. Exp. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Op. Exp. Benchmarks
CompanyOp. Exp.
CTMX : CYTOMX THERAPEUTICS INC $ 97.97MXNCR : XENCOR INC $ 291.66MARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ 194.69MYMAB : Y-MABS THERAPEUTICS INC $ 96.23MGLUE : MONTE ROSA THERAPEUTICS INC $ 163.03MHRTX : HERON THERAPEUTICS INC $ 110.46MNKTR : NEKTAR THERAPEUTICS $ 163.28MPACB : PACIFIC BIOSCIENCES OF CALIFORNIA INC $ 743.75MLXRX : LEXICON PHARMACEUTICALS INC $ 176.32MVNDA : VANDA PHARMACEUTICALS INC $ 292.88M

Definition of Operating Expenses

[Income Statement] Operating expenses are costs like [SGnA] and [RnD] incurred during regular operations. These costs can either be fixed or variable, and are dependend on the type of business. Common examples are rent, insurance, marketing, and payroll, it excludes cost of revenue [CoR].

RGNX - Operating Expenses, Last 5 years

$ 221.55M

Minimum

Sep 30, 2020

$ 325.59M

Maximum

Jun 30, 2023

$ 286.93M

Average

$ 292.38M

Median

Op. Exp. Benchmark Analysis

The chart above depicts the distribution of Op. Exp. for companies in the Total Stock Market. The average Op. Exp. of the companies is $ 232.5M with a standard deviation of $ 271.53M.
The following table provides additional summary stats:
Op. Exp. in the Market:
filtered constituents3.46K
min$ -391.56M
max$ 1.16B
average$ 232.5M
median$ 120.21M
std$ 271.53M